Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/19/21 (What's New)

Summary

  • NNRTIs bind to and stereotypically inhibit HIV reverse transcriptase outside of active domain
  • Currently, there are 6 FDA-approved NNRTIs (Table 9)
  • Rash is a classwide adverse effect with use of currently approved NNRTIs
    • Efavirenz
      Etravirine
        Rilpivirine
          Doravirine

          Action required

          Keywords: Dermatologic Complications, Initial Antiretroviral Therapy, Pregnancy, Special Populations, Treatment Complications

          ©2020 Clinical Care Options, LLC. All Rights Reserved.

          The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.